Medicare Enrolled
Dr. Victor Yu, M.D.
Gastroenterology · Irvine, CA
Practice pattern: Clinical Cardiology
— Primarily office-based clinical cardiology
Low-engagement
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating.
This page presents federal public records about Dr. Yu from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Yu?
Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. Yu
Dr. Victor Yu is a gastroenterology specialist in Irvine, CA, with 19 years of NPI registration. Based on federal Medicare data, Dr. Yu performed 1,001 Medicare services across 949 unique beneficiaries.
Between the years covered by Open Payments, Dr. Yu received a total of $12,355 from 48 pharmaceutical and/or device companies across 690 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in gastroenterology. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Yu is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 19 years in practice
▲ Top 34% volume in CA
$12,355 industry payments
Medicare Practice Summary
Medicare Utilization ↗1,001
Medicare services
Top 34% in CA for gastroenterology
949
Unique beneficiaries
$120
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
~53 Medicare services per year of practice
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| New patient office visit (45-59 min) An initial office visit for a new patient lasting between 45 and 59 minutes. This code covers the total time spent by the physician or qualified healthcare professional on the date of the encounter. |
231 | $128 | $360 |
| Office visit, established patient (30-39 min) A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition. |
212 | $102 | $225 |
| Upper GI endoscopy with biopsy A procedure to collect tissue samples from the esophagus, stomach, or upper small intestine using a flexible tube with a camera. The samples are examined to check for abnormalities. |
193 | $82 | $763 |
| Colonoscopy with biopsy A procedure to collect tissue samples from the large intestine using a flexible tube with a camera. The samples are examined to check for abnormalities or disease. |
66 | $142 | $987 |
| Colonoscopy for colorectal cancer screening, high risk A colonoscopy performed to screen for colorectal cancer in individuals identified as being at high risk for the disease. |
52 | $192 | $500 |
| New patient office visit (30-44 min) An initial office visit for a new patient lasting between 30 and 44 minutes. This code is used when the total time spent on the date of the encounter falls within this range. |
50 | $92 | $250 |
| Colon polyp removal with endoscopic snare This procedure removes polyps or growths from the large bowel using a flexible tube with a camera and a wire loop tool. The snare is used to cut off the growths during the examination. |
41 | $203 | $1,250 |
| Colonoscopy for colorectal cancer screening A colonoscopy performed to screen for colorectal cancer in individuals who are not at high risk for the disease. |
41 | $188 | $500 |
| Colonoscopy A diagnostic exam of the large bowel using a flexible endoscope to visualize the interior of the colon. |
29 | $144 | $950 |
| Initial hospital admission, high complexity Initial hospital inpatient or observation care for a new patient involving high-level medical decision making, with at least 75 minutes total time on the date of the encounter. |
27 | $149 | $450 |
| Hospital follow-up visit, high complexity Subsequent hospital inpatient or observation care for an existing patient involving high-level medical decision making, with at least 50 minutes total time on the date of the encounter. |
19 | $102 | $225 |
| Helicobacter pylori breath test A diagnostic test that analyzes a patient's breath to detect the presence of Helicobacter pylori bacteria. This procedure is used to identify infections associated with the stomach and upper digestive tract. |
14 | $66 | $190 |
| Helicobacter pylori drug administration This procedure involves the administration of a medication specifically used to treat Helicobacter pylori infection. |
14 | $8 | $25 |
| Balloon dilation of esophagus, stomach, or upper small bowel, less than 3.0 cm A procedure using a flexible endoscope to widen a narrowed section of the esophagus, stomach, or upper small bowel with a balloon that is less than 3.0 cm in length. |
12 | $125 | $1,600 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.
Industry Payment Transparency
Open Payments through 2024 ↗$12,355
Total received (2018-2024)
Avg $1,765/year across 7 years
Top 16% in CA for gastroenterology
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
48
Companies
690
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →
Payment profile
Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$12,355 (100.0%)
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024
$2,551
2023
$2,326
2022
$2,208
2021
$1,285
2020
$827
2019
$1,597
2018
$1,561
Payments by company (2024)
Consulting
Speaking
Meals & Travel
Research
ABBVIE INC.
$1,091
Janssen Biotech, Inc.
$267
Takeda Pharmaceuticals U.S.A., Inc.
$231
GENZYME CORPORATION
$204
AIMMUNE THERAPEUTICS, INC.
$197
Lilly USA, LLC
$146
Salix Pharmaceuticals, a division of Bausch Health US, LLC
$88
Gilead Sciences, Inc.
$75
Madrigal Pharmaceuticals
$66
Regeneron Healthcare Solutions, Inc.
$52
QOL Medical, LLC
$47
Celltrion USA Inc.
$32
AstraZeneca Pharmaceuticals LP
$21
Celgene Corporation
$18
Medtronic, Inc.
$18
Top 3 companies account for 62.3% of 2024 payments
All-time payments by company (2018-2024) ›
ABBVIE INC.
$1,809
Takeda Pharmaceuticals U.S.A., Inc.
$1,532
AbbVie Inc.
$1,506
Janssen Biotech, Inc.
$916
Salix Pharmaceuticals, a division of Bausch Health US, LLC
$909
Gilead Sciences, Inc.
$560
AbbVie, Inc.
$508
Nestle HealthCare Nutrition Inc.
$506
GENZYME CORPORATION
$409
Allergan Inc.
$388
Regeneron Healthcare Solutions, Inc.
$338
Janssen Scientific Affairs, LLC
$239
NESTLE HEALTHCARE NUTRITION INC.
$204
AIMMUNE THERAPEUTICS, INC.
$197
PFIZER INC.
$197
Lilly USA, LLC
$159
Celgene Corporation
$154
Medtronic USA, Inc.
$139
Daiichi Sankyo Inc.
$137
E.R. Squibb & Sons, L.L.C.
$133
Covidien LP
$123
Cook Medical LLC
$112
Alfasigma USA, Inc.
$96
Intercept Pharmaceuticals, Inc.
$95
QOL Medical, LLC
$77
Prometheus Laboratories Inc.
$72
Ferring Pharmaceuticals Inc.
$72
RedHill Biopharma Inc.
$67
Madrigal Pharmaceuticals
$66
Welch Allyn
$64
Synergy Pharmaceuticals Inc
$64
Shionogi Inc
$58
Medtronic, Inc.
$57
Allergan, Inc.
$57
Ironwood Pharmaceuticals, Inc
$52
Celltrion USA Inc.
$32
Echosens North America, Inc.
$29
Alnylam Pharmaceuticals Inc.
$28
Boston Scientific Corporation
$25
Perspectum Diagnostics Ltd
$24
Lucid Diagnostics Inc.
$23
AstraZeneca Pharmaceuticals LP
$21
Organon LLC
$19
W. L. Gore & Associates, Inc.
$18
Olympus America Inc.
$18
Dova Pharmaceuticals
$17
VIVUS, Inc.
$14
Braintree Laboratories, Inc.
$14
Top 3 companies account for 39.2% of all-time payments
Associated products mentioned in payments ›
ACQUIRE · ANDEXXA · APRISO · AVYCAZ · Aemcolo · Amitiza · BRAVO · Bravo · CIMZIA · CLENPIQ · CREON · Cook Medical Endoscopic Ultrasound · Creon · DUOPA · DUPIXENT · Dexilant · Doptelet · ENTYVIO · EOHILIA · EndoFlip · Entyvio · Fibroscan · GENERAL POLYPECTOMY · GIVLAARI · GORE CARDIOFORM Septal Occluder · HADLIMA · HUMIRA · Humira · INFLECTRA · INJECTAFER · INTERSTIM · LINZESS · Linzess · LiverMultiScan · MAVYRET · MOTEGRITY · MOVIPREP · Mavyret · Motegrity · Movantik · Mulpleta · OCALIVA · OMVOH · Olympus Tissue Acquisition Devices · PANCREAZE · PILLCAM · REBYOTA · RELISTOR ORAL · REMICADE · RESMETIROM · RINVOQ · SKYRIZI · STELARA · SUCRAID · SUPREP BOWEL PREP · Spot Vital Signs · Sucraid · Symproic · TREMFYA · TRULANCE · Talicia · Trulance · UCERIS · VIBERZI · VOWST · XELJANZ · XIFAXAN · XIFAXANIBSD · ZENPEP · ZEPOSIA · ZYMFENTRA · Zelnorm
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
Most payments (100%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians.
Geographic Context
Gastroenterologists within 10 mi
203
Per 100K population
6.4
County median income
$113,702
Nearest hospital
HOAG ORTHOPEDIC INSTITUTE
0.0 mi
0.0 mi
Data Sources
| Provider Registry | ✓ NPPES | Weekly updates |
| Medicare Enrollment | ✓ PECOS | Monthly updates |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not public | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →
Summary
Dr. Yu is a clinical cardiology specialist, with moderate Medicare volume, with low-engagement industry engagement in the top 16% of CA peers, with 19 years of NPI registration.
This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →
Frequently Asked Questions
Is Dr. Yu experienced with new patient office visit (45-59 min)?
Based on Medicare claims data, Dr. Yu performed 231 new patient office visit (45-59 min) services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Yu receive payments from pharmaceutical companies?
Yes. Dr. Yu received a total of $12,355 from 48 companies across 690 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Yu's costs compare to other gastroenterologists in Irvine?
Dr. Yu's average Medicare payment per service is $120. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Yu) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
Explore related providers
Specialty guide
Understanding Gastroenterology
Common procedures, typical costs, and what industry payments mean in gastroenterology.
Same specialty & city
Gastroenterologists in Irvine
Browse gastroenterologists in Irvine ranked by procedure volume and transparency data.
Highest volume
Top Gastroenterologists in CA
Gastroenterologists ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Gastroenterologists in CA
Which CA gastroenterologists receive the most from drug and device companies.
By company
ABBVIE INC. Payments to Doctors
See all physicians who received payments from ABBVIE INC.
By company
Takeda Pharmaceuticals U.S.A., Inc. Payments to Doctors
See all physicians who received payments from Takeda Pharmaceuticals U.S.A., Inc.
By company
AbbVie Inc. Payments to Doctors
See all physicians who received payments from AbbVie Inc.
About this page
All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology